PEX10 and prostate carcinoma: These results suggest that there may be an enhancer in the PEX10 2411280-2410760 region, and AR and FOXA1 cooperate to activate this enhancer and promote the expression of PEX10. AR and FOXA1 frequently co-regulate gene expression in prostate cancer [10, 35].